HIGHLIGHTS
- who: TGM and colleagues from the Sichuan University, China have published the research work: Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker, in the Journal: (JOURNAL)
- what: TIDE analysis was provided to evaluate if TGM3 has the potential therapeutic target for ICI therapy. Because the online RNA-seq data include bulk-seq data, which contains information of various cells, the authors focused on comparing paired tumor tissues to shed lighter on the mechanism. The authors showed that TGM3 expression was negatively correlated with B cells, DCs and neutrophil cells in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.